MetaStat receives Massachusetts State Clinical Laboratory License

Tuesday, September 29, 2015

MetaStat, Inc., a molecular diagnostic company, today announced it successfully passed its Massachusetts laboratory inspection and has received a Massachusetts state license for its digital pathology laboratory in Boston, Massachusetts.

“Receiving the Massachusetts state license for our digital pathology laboratory is an important step for MetaStat,” said Douglas A. Hamilton, President and Chief Executive Officer of Metastat. “Working alongside the experts at South Shore Consultants, MetaStat has developed quality systems and procedures to ensure our next generation diagnostic products meet and exceed the rigorous standards of clinical practice as required by our customers.”

MetaStat can begin to process physician orders and run tissue samples from most U.S. states, the final major step in achieving certification from the U.S. Department of Health and Human Services’ Centers for Medicare and Medicaid Services (CMS) under the Clinical Laboratory Improvement Amendments (CLIA) of 1988 for its digital pathology laboratory in Boston, Massachusetts.